Lived experiences, even the difficult ones, can become sources of strength, empathy, and connection. Developing greater body ...
In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, reflects on the gap between sponsor expectations and statistical reality, drawing on lessons from the COVID era to argue for more ...
Immuneering will present an analysis of circulating tumor DNA (ctDNA) from ≥64 patients with RAS-mutant solid tumors treated with atebimetinib, showing that acquired MAPK pathway alterations are ...
In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, makes the case for generalized pairwise comparisons and ...
Full-year 2025 revenue increased 10% year-over-year to $116.6 million, within revised guidance rangeFull year 2026 revenue guidance of $100.5 to ...
Lean Drops, an innovative liquid dietary supplement targeting metabolic function and appetite regulation, has officially ...
(UroToday.com) The 2026 European Association of Urology (EAU) Annual Meeting held in London, U.K., was host to the Hormone sensitive metastatic prostate cancer: Thematic Session. Dr. Declan Murphy ...
Peptide-based molecules have increasingly been positioned not merely as isolated biochemical entities, but as conceptual ...
Nia Therapeutics announced today that it received FDA breakthrough device designation for its Smart Neurostimulation System ...
Compare the top Series 63 exam prep courses and find the best match for your learning style to build confidence and pass your ...
A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results